Background: Postpartum anemia imposes a disproportionately substantial disease burden during a critical period of maternal-infant interaction. Postpartum anemia requires prevention and treatment not only for that particular period but also to ensure good health with enough iron stores at the start of the next pregnancy. Among various parenteral iron preparations, single-dose intravenous (FCM) ferric carboxymaltose is more effective to cure anemia.